PDI Healthcare Simplifies Ease and Speed of SSI and HAI Protection with New Profend™ Nasal Decolonization Kit

Categories: Healthcare & Press Release February 20, 2018

Fast-acting, effective 10 percent PVP-iodine Nasal swabstick designed to maximize patient comfort, ease application process in support of antibiotic stewardship

ORANGEBURG, NY – February 20, 2018 – PDI, a leader in infection prevention products and solutions, today announced the launch of its Profend Nasal Decolonization Kit, the first in a suite of Profend products designed to help prevent surgical site infections (SSIs) and other hospital-acquired infections (HAIs). Profend nasal swabsticks are pre-saturated with 10 percent Povidone-iodine to deliver a fast time to full efficacy against a leading risk factor for SSIs, S. aureus and methicillin-resistant S. aureus (MRSA) in patients’ noses, without the risk of antibiotic resistance. At any given time, about 30 percent of the adult population is nasally colonized, according to a study from the Journal of Clinical Microbiology.

The Profend Nasal Decolonization Kit uses a unique “snap and swab” design that simplifies the decolonization process, while offering convenience for clinicians and supporting patient comfort. Clinician-applied for assured treatment compliance, the swabstick’s dry-handle design minimizes mess during application, while the small nasal swab offers easy application and enhanced comfort for patients. Treatment time is a quick 60 seconds – up to two-and-a-half times faster than other nasal decolonization products on the market. Additionally, Profend uses PVP-iodine, a broad-spectrum antiseptic proven effective against S. aureus and MRSA with no known pathogen resistance, as demonstrated by Houang et al. in the Journal of Clinical Pathology, thereby supporting antibiotic stewardship. In a study of healthy volunteers, Profend nasal swabsticks reduced S. aureus by 99.7% at one hour and 99.9% at 12 hours, according to a PDI in vivo clinical research.

“Hospital acquired and surgical site infections are an increasingly complex and dynamic threat to the health of patients,” said Elise Tordella, Vice President, Marketing, PDI Healthcare. “Our response to this evolving hazard, the Profend Nasal Decolonization Kit, has been met with a positive clinical response as 90 percent of surveyed clinicians expressed a preference for it over other nasal PVP-iodine products. Also, 100 percent of these clinicians expressed the belief that their patients would prefer the Profend solution to other leading decolonization products on the market.”

PDI will showcase its Profend Nasal Decolonization Kit for the first time at the 2018 Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo, occurring March 24-28 in New Orleans. The product will be available for delivery beginning in March 2018. To learn more, click here.


About PDI Healthcare: PDI offers a broad range of evidence-based, market-leading Interventional Care, Environment of Care, and Patient Care solutions, all designed to help reduce preventable infections, control healthcare costs, and ultimately help save lives. It’s all part of PDI’s passion to Be The Difference®, every day. To learn more, visit pdihc.com.